Dario Eklund
Chief Executive Officer chez SANTHERA PHARMACEUTICALS HOLDING AG
Fortune : 27 118 $ au 31/03/2024
Profil
Dario Eklund currently works at Santhera Pharmaceuticals Holding AG, as Chief Executive Officer from 2019 and Vifor Fresenius Medical Care Renal Pharma Ltd., as Member-Supervisory Board.
Mr. Eklund also formerly worked at Novartis AG, as Commercial Director from 1994 to 2002, Organogenesis, Inc., as VP-Business Development & Gintuit Business Unit, Sanofi, as General Manager-Switzerland from 2002 to 2004, Vifor Pharma AG, as Chief Commercial Officer from 2017 to 2019, Aventis Pharma AG, as General Manager-Switzerland Region, and Vifor Pharma Management AG, as Head-Global Business Operations.
Mr. Eklund received his graduate degree from Hanken Svenska Handelshögskolan.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 31/12/2022 | 2 500 ( 0,02% ) | 27 118 $ | 31/03/2024 |
Postes actifs de Dario Eklund
| Sociétés | Poste | Début |
|---|---|---|
| SANTHERA PHARMACEUTICALS HOLDING AG | Chief Executive Officer | 01/12/2019 |
Vifor Fresenius Medical Care Renal Pharma Ltd.
 Vifor Fresenius Medical Care Renal Pharma Ltd. Pharmaceuticals: MajorHealth Technology Vifor Fresenius Medical Care Renal Pharma Ltd. engages in the research in as well as development, marketing, and distribution of pharmaceutical products used in the field of nephrology for the treatment of patients suffering from chronic kidney disease. It offers products specialized in anemia, mineral, bone, and cardio-renal management. The company was founded on November 26, 2010 and is headquartered in St. Gallen, Switzerland. | Director/Board Member | - |
Anciens postes connus de Dario Eklund
| Sociétés | Poste | Fin |
|---|---|---|
Vifor Pharma Management AG
 Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland. | Corporate Officer/Principal | 30/09/2019 |
| VIFOR PHARMA | Corporate Officer/Principal | 30/09/2019 |
| SANOFI | Corporate Officer/Principal | 01/01/2004 |
| NOVARTIS AG | Corporate Officer/Principal | 01/01/2002 |
Organogenesis, Inc.
 Organogenesis, Inc. Medical SpecialtiesHealth Technology Organogenesis, Inc. designs and manufactures regenerative medical products. It offers Apligraf, a living cell-based product indicated for the treatment of venous leg ulcers and diabetic foot ulcers and Dermagraft, a product for the treatment of diabetic foot ulcers. The firm also provides bioactive wound healing, biosurgery, and aesthetic medicine containing living cells and natural connective tissues. The company was founded in 1985 and is headquartered in Canton, MA. | Corporate Officer/Principal | - |
Formation de Dario Eklund
| Hanken Svenska Handelshögskolan | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| SANOFI | Health Technology |
| NOVARTIS AG | Health Technology |
| SANTHERA PHARMACEUTICALS HOLDING AG | Health Technology |
| Entreprise privées | 5 |
|---|---|
Organogenesis, Inc.
Organogenesis, Inc. Medical SpecialtiesHealth Technology Organogenesis, Inc. designs and manufactures regenerative medical products. It offers Apligraf, a living cell-based product indicated for the treatment of venous leg ulcers and diabetic foot ulcers and Dermagraft, a product for the treatment of diabetic foot ulcers. The firm also provides bioactive wound healing, biosurgery, and aesthetic medicine containing living cells and natural connective tissues. The company was founded in 1985 and is headquartered in Canton, MA. | Health Technology |
Vifor Pharma AG
 Vifor Pharma AG Pharmaceuticals: MajorHealth Technology Vifor Pharma AG is a pharmaceutical company, which engages in the research, development, production, and marketing of therapeutic products. It operates through the following geographical segments: Switzerland, Europe, USA, Rest of World, and Group. The firm offers products for iron deficiency, nephrology, and cardio-renal therapies. It specializes in strategic global partnering, in-licensing and developing, manufacturing and marketing pharmaceutical products for precision patient care. The company was founded in 1927 and is headquartered in St. Gallen, Switzerland. | Health Technology |
| Aventis Pharma AG | |
Vifor Pharma Management AG
Vifor Pharma Management AG Pharmaceuticals: MajorHealth Technology Vifor Pharma Management AG develops and manufactures pharmaceuticals products for the treatment of iron deficiency. It also offers a diversified portfolio of prescription medicines as well as over-the-counter products. The company operates in the following key business areas: iron deficiency with and without anemia, kidney disease, infectious diseases/OTX products and consumer healthcare, with a focus on non-prescription products. Vifor Pharma Management was founded by Caspar Friedrich Hausmann in 1872 and is headquartered in Glattbrugg, Switzerland. | Health Technology |
Vifor Fresenius Medical Care Renal Pharma Ltd.
Vifor Fresenius Medical Care Renal Pharma Ltd. Pharmaceuticals: MajorHealth Technology Vifor Fresenius Medical Care Renal Pharma Ltd. engages in the research in as well as development, marketing, and distribution of pharmaceutical products used in the field of nephrology for the treatment of patients suffering from chronic kidney disease. It offers products specialized in anemia, mineral, bone, and cardio-renal management. The company was founded on November 26, 2010 and is headquartered in St. Gallen, Switzerland. | Health Technology |
